Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Go back to Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Kestra Medical Technologies, Ltd. (KMTS) Misses Q2 EPS by 9c, Beats on Revenue

July 14, 2026 4:03 PM EDT

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q2 EPS of ($0.67), $0.09 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $28.64 million, versus $26.5 million reported last year.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.

... More